Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
Isoniazid (INH) is an anti-tuberculosis drug; however the underlying cause of its various side effects are not understood. Here the authors identified lysine isonicotinylation as a histone modification on chromatin that is metabolically regulated by INH and its metabolites.
Enregistré dans:
Auteurs principaux: | Yuhan Jiang, Yixiao Li, Cheng Liu, Lei Zhang, Danyu Lv, Yejing Weng, Zhongyi Cheng, Xiangmei Chen, Jun Zhan, Hongquan Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a75ea7e77a4d4edc993060b25acbbf6e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
par: M Pourhajibagher, et autres
Publié: (2012) -
Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
par: Edward Chia-Cheng Lai, et autres
Publié: (2021) -
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
par: Diana Machado, et autres
Publié: (2012) -
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
par: Lin HS, et autres
Publié: (2016) -
Lysine benzoylation is a histone mark regulated by SIRT2
par: He Huang, et autres
Publié: (2018)